Want to see TBIO full AI Analyst Report?
Telesis Bio (TBIO) Income Statement
Telesis Bio Income Statement
Last quarter (Q3 2024), Telesis Bio's total revenue was $1.57M, a decrease of 71.85% from the same quarter last year. In Q3, Telesis Bio's net income was $-6.64M. See Telesis Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| $ 27.51M | $ 27.43M | $ 11.04M | $ 6.58M | $ 4.80M | |
| $ 16.95M | $ 15.60M | $ 4.30M | $ 3.63M | $ -4.08M | |
| $ 63.49M | $ 62.08M | $ 39.67M | $ 19.99M | $ 2.89M | |
| Depreciation and Amortization | $ 4.10M | $ 2.88M | $ 1.57M | $ 1.46M | $ 857.00K |
| $ -40.49M | $ -43.62M | $ -36.00M | $ -15.86M | $ -5.96M | |
| $ -46.54M | $ -46.48M | $ -35.37M | $ -16.36M | $ -6.98M | |
| $ -1.16M | $ -1.96M | $ -3.57M | $ -1.64M | $ -1.33M | |
| $ -47.70M | $ -48.45M | $ -38.94M | $ -18.00M | $ -8.30M | |
| $ -47.72M | $ -48.47M | $ -38.96M | $ -18.01M | $ -8.30M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.59 | $ -1.65 | $ -1.33 | $ -0.62 | $ -0.20 |
| Diluted EPS | $ -1.59 | $ -1.65 | $ -1.33 | $ -0.62 | $ -0.20 |
| Weighted Average Shares Outstanding | 29.93M | 29.46M | 29.32M | 29.23M | 40.76M |
| Weighted Average Shares Outstanding (Diluted) | 29.93M | 29.46M | 29.32M | 29.23M | 40.76M |
Currency in USD
